Milica Pešić

3.6k total citations
135 papers, 2.4k citations indexed

About

Milica Pešić is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Milica Pešić has authored 135 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 39 papers in Oncology and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Milica Pešić's work include Drug Transport and Resistance Mechanisms (25 papers), Cancer therapeutics and mechanisms (15 papers) and Natural product bioactivities and synthesis (12 papers). Milica Pešić is often cited by papers focused on Drug Transport and Resistance Mechanisms (25 papers), Cancer therapeutics and mechanisms (15 papers) and Natural product bioactivities and synthesis (12 papers). Milica Pešić collaborates with scholars based in Serbia, Spain and Italy. Milica Pešić's co-authors include Ana Podolski-Renić, Jasna Banković, Jelena Dinić, Tijana Stanković, Nikola Tanić, Sabera Ruždijić, Zorica Milošević, Vlatka Vajs, Vele Tešević and Ivanka Marković and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Milica Pešić

127 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milica Pešić Serbia 29 1.3k 476 308 299 214 135 2.4k
Amareshwar T.K. Singh United States 17 1.2k 1.0× 458 1.0× 208 0.7× 368 1.2× 120 0.6× 32 2.3k
Agustín Lahoz Spain 33 1.5k 1.2× 503 1.1× 188 0.6× 264 0.9× 113 0.5× 90 3.6k
Vaishali Aggarwal India 18 1.1k 0.9× 462 1.0× 168 0.5× 373 1.2× 112 0.5× 28 2.5k
Rongsheng Tong China 32 1.8k 1.5× 619 1.3× 298 1.0× 233 0.8× 183 0.9× 116 4.1k
Xing Du China 22 1.5k 1.2× 278 0.6× 193 0.6× 343 1.1× 105 0.5× 47 2.7k
Konstantinos Dimas Greece 26 1.1k 0.9× 453 1.0× 330 1.1× 169 0.6× 82 0.4× 85 2.1k
Parvez Κhan India 33 1.6k 1.3× 523 1.1× 618 2.0× 198 0.7× 78 0.4× 85 2.9k
Fang Bai China 33 2.0k 1.6× 405 0.9× 302 1.0× 326 1.1× 95 0.4× 173 3.5k
Rebecca Shin-Yee Wong Malaysia 15 1.6k 1.3× 410 0.9× 276 0.9× 486 1.6× 63 0.3× 51 3.0k
Paul Fitzpatrick United States 31 1.9k 1.6× 333 0.7× 265 0.9× 245 0.8× 68 0.3× 65 3.1k

Countries citing papers authored by Milica Pešić

Since Specialization
Citations

This map shows the geographic impact of Milica Pešić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milica Pešić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milica Pešić more than expected).

Fields of papers citing papers by Milica Pešić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milica Pešić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milica Pešić. The network helps show where Milica Pešić may publish in the future.

Co-authorship network of co-authors of Milica Pešić

This figure shows the co-authorship network connecting the top 25 collaborators of Milica Pešić. A scholar is included among the top collaborators of Milica Pešić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milica Pešić. Milica Pešić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Isca, Vera M. S., Jelena Dinić, Milica Pešić, et al.. (2024). Investigating SAR Insights into Royleanones for P-gp Modulation. SHILAP Revista de lepidopterología. 35–35.
4.
Dinić, Jelena, Sofija Jovanović Stojanov, Thomas Mohr, et al.. (2024). Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. Cancers. 16(11). 1984–1984. 3 indexed citations
6.
Dinić, Jelena, et al.. (2024). Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine. Life. 14(9). 1142–1142. 1 indexed citations
8.
Stojanov, Sofija Jovanović, Adrián Puerta, Jelena Dinić, et al.. (2024). Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases. Bioorganic Chemistry. 145. 107168–107168. 6 indexed citations
9.
Puerta, Adrián, Jelena Dinić, Sofija Jovanović Stojanov, et al.. (2023). Biotinylated selenocyanates: Potent and selective cytostatic agents. Bioorganic Chemistry. 133. 106410–106410. 10 indexed citations
11.
Segura‐Collar, Berta, Ricardo Gargini, Juan Manuel Sepúlveda-Sánchez, et al.. (2022). On optimal temozolomide scheduling for slowly growing glioblastomas. Neuro-Oncology Advances. 4(1). vdac155–vdac155. 8 indexed citations
12.
Kostić, Ana, Milka Jadranin, Milica Pešić, et al.. (2021). Two new jatrophane diterpenes from the roots of Euphorbia nicaeensis. Journal of the Serbian Chemical Society. 86(12). 1219–1228. 4 indexed citations
13.
Stupar, Petar, Ana Podolski-Renić, María Inés Villalba, et al.. (2021). Nano-Motion Analysis for Rapid and Label Free Assessing of Cancer Cell Sensitivity to Chemotherapeutics. Medicina. 57(5). 446–446. 8 indexed citations
14.
Momčilović, Stefan, et al.. (2020). Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension. European Journal of Clinical Pharmacology. 76(11). 1539–1546. 4 indexed citations
15.
Podolski-Renić, Ana, Jelena Dinić, Tijana Stanković, et al.. (2019). Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 19 indexed citations
16.
Fallacara, Anna Lucia, Claudio Zamperini, Ana Podolski-Renić, et al.. (2019). A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor. Cancers. 11(6). 848–848. 39 indexed citations
17.
Dinić, Jelena, et al.. (2018). Alkylamino and aralkylamino derivatives of avarone and its mimetic as selective agents against non-small cell lung cancer cells, their antibacterial and antifungal potential. Journal of the Serbian Chemical Society. 83(11). 1193–1207. 2 indexed citations
18.
Podolski-Renić, Ana, Jelena Dinić, José M. Ayuso, et al.. (2016). Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells—Characterization of a New in Vivo Model. Molecules. 21(7). 843–843. 9 indexed citations
19.
Xavier, Cristina P. R., Milica Pešić, & M. Helena Vasconcelos. (2016). Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models. Current Cancer Drug Targets. 16(3). 226–237. 32 indexed citations
20.
Novaković, Miroslav, Milica Pešić, Snežana Trifunović, et al.. (2013). Diarylheptanoids from the bark of black alder inhibit the growth of sensitive and multi-drug resistant non-small cell lung carcinoma cells. Phytochemistry. 97. 46–54. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026